BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9577600)

  • 1. [Ultrasound scattering properties of Albunex microspheres].
    Takamoto T; Shiina T
    Nihon Rinsho; 1998 Apr; 56(4):871-5. PubMed ID: 9577600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
    Hasegawa M; Saiki Y; Kayano H; Katagiri T
    Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albunex--a new ultrasound contrast agent. Effects on hemodynamics, contrast, and biodistribution in different species.
    Walday P; Ostensen J; Tolleshaug H; Holtz E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S142-4. PubMed ID: 7928211
    [No Abstract]   [Full Text] [Related]  

  • 4. Albunex and beyond.
    Ostensen J
    Clin Radiol; 1996 Feb; 51 Suppl 1():8-10. PubMed ID: 8605776
    [No Abstract]   [Full Text] [Related]  

  • 5. Sonographic evaluation of intervillous flow in early pregnancy: use of echo-enhancement agents.
    Simpson NA; Nimrod C; De Vermette R; Leblanc C; Fournier J
    Ultrasound Obstet Gynecol; 1998 Mar; 11(3):204-8. PubMed ID: 9589145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
    Bleeker H; Shung K; Barnhart J
    J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro.
    Ota T; Hillman ND; Craig D; Kisslo J; Smith PK
    J Am Soc Echocardiogr; 1997; 10(1):31-40. PubMed ID: 9046491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of an immune response to Albunex, a new ultrasound contrast agent based on air-filled albumin microspheres.
    Christiansen C; Vebner AJ; Muan B; Vik H; Haider T; Nicolaysen H; Skotland T
    Int Arch Allergy Immunol; 1994 Aug; 104(4):372-8. PubMed ID: 8038616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thresholds for inertial cavitation in albunex suspensions under pulsed ultrasound conditions.
    Chang PP; Chen WS; Mourad PD; Poliachik SL; Crum LA
    IEEE Trans Ultrason Ferroelectr Freq Control; 2001 Jan; 48(1):161-70. PubMed ID: 11367783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of renal blood flow with contrast ultrasonography.
    Aronson S; Wiencek JG; Feinstein SB; Heidenreich PA; Zaroff JG; Walker R; Roizen MF
    Anesth Analg; 1993 May; 76(5):964-70. PubMed ID: 8484552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustic cavitation nuclei survive the apparent ultrasonic destruction of Albunex microspheres.
    Brayman AA; Miller MW
    Ultrasound Med Biol; 1997; 23(5):793-6. PubMed ID: 9253828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent.
    Wilson B; Shung KK; Hete B; Levene H; Barnhart JL
    Ultrasound Med Biol; 1993; 19(3):181-91. PubMed ID: 8511824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound scattering properties of Albunex microspheres.
    de Jong N; Hoff L
    Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study on efficacy of myocardial opacification owing to difference of echocardiographic contrast agents].
    Suzuki M; Yamaguchi T
    Nihon Rinsho; 1998 Apr; 56(4):909-13. PubMed ID: 9577607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.
    Wible JH; Wojdyla JK; Bales GL; McMullen WN; Geiser EA; Buss DD
    J Am Soc Echocardiogr; 1996; 9(4):442-51. PubMed ID: 8827627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of renal blood flow by contrast ultrasonography: preliminary results.
    Voci P; Heidenreich P; Aronson S; Wiencek JG; Zaroff JG; Feinstein SB; Reale A
    Cardiologia; 1989 Dec; 34(12):1001-6. PubMed ID: 2699440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consideration about the contribution to acoustic backscatter from Albunex microspheres with different sizes.
    Hoff L; Christiansen C; Skotland T
    J Ultrasound Med; 1994 Mar; 13(3):181-2. PubMed ID: 7932974
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrasound contrast. Oral and i.v. agents amplify the image.
    Barr RG
    Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114
    [No Abstract]   [Full Text] [Related]  

  • 20. Time-domain ultrasonic contrast blood flowmetry.
    Shung KK; Flenniken RR
    Ultrasound Med Biol; 1995; 21(1):71-8. PubMed ID: 7754580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.